Evidence map›Paper›PMID 41199850›Full record

ReviewFrontiers in oncology2025

Multidisciplinary management of intracardiac tumor thrombus in low-grade endometrial stromal sarcoma: case report and literature review.

Hanke Zhang, Jinhua Chen, Chao Yang, Si Chen, Miao Wang, Xiaoyan Xin, Hongbo Wang, Xiaowu Zhu

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hanke Zhang *Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jinhua Chen *Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chao YangDepartment of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Si ChenDepartment of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Miao WangDepartment of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaoyan XinDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hongbo WangDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiaowu ZhuDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The low-grade endometrial stromal sarcoma (LG-ESS) represents a slowly proliferating subtype of endometrial stromal tumor but exhibits a preference for late-stage recurrence. Incidence of invasion into major blood vessels and the heart is exceedingly uncommon in this particular neoplasm. We describe a patient with recurrent LG-ESS whose tumor mainly involved the right ovary and right kidney and extended from the ovarian vein to the right atrium. Furthermore, we comprehensively review existing literature on 35 patients exhibiting similar manifestations. In these 36 cases, tumor thrombus primarily extended to the inferior vena cava (n=17), with a minority extending to the right atrium (n=12), while no cases were detected when the tumor thrombus had just extended to the iliac blood vessels, indicating that LG-ESS exhibits an insidious onset during early-stage vascular invasion. It is advisable for comprehensive examination and diligent follow-up in high-risk patients. 19 cases with complete tumor resection were followed up, and all except two patients remained alive with no evidence of disease. Among the 5 cases of mortality, 2 cases did not undergo surgical intervention, while in 3 cases where surgery was performed, complete tumor resection could not be achieved. The causes of death in these patients were related to disease progression or concurrent cardiovascular events. These findings underscore the importance of cytoreductive surgery adhering to the tumor-free principle, or at least removing the lesions in the major blood vessels and heart to prevent acute embolism and sudden demise, which usually requires multidisciplinary teamwork.

Indexed as

cytoreductive surgerylow-grade endometrial stromal sarcomametastasismultidisciplinary managementright atrium

Identifiers

PMID41199850
PMCPMC12585988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.